Correlation Between Aerovate Therapeutics and Data443 Risk

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Data443 Risk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Data443 Risk into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Data443 Risk Mitigation, you can compare the effects of market volatilities on Aerovate Therapeutics and Data443 Risk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Data443 Risk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Data443 Risk.

Diversification Opportunities for Aerovate Therapeutics and Data443 Risk

-0.04

Correlation Coefficient

Aerovate Therapeutics  Data443 Risk

Good diversification

The 3 months correlation between Aerovate and Data443 is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Data443 Risk Mitigation in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Data443 Risk Mitigation and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Data443 Risk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Data443 Risk Mitigation has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Data443 Risk go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Data443 Risk

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 56.21 times less return on investment than Data443 Risk. But when comparing it to its historical volatility, Aerovate Therapeutics is 21.49 times less risky than Data443 Risk. It trades about 0.06 of its potential returns per unit of risk. Data443 Risk Mitigation is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  11.00  in Data443 Risk Mitigation on October 21, 2024 and sell it today you would lose (2.21) from holding Data443 Risk Mitigation or give up 20.09% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  Data443 Risk Mitigation

Aerovate Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Data443 Risk Mitigation

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Data443 Risk Mitigation are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, Data443 Risk unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aerovate Therapeutics and Data443 Risk

The main advantage of trading using opposite Aerovate Therapeutics and Data443 Risk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Data443 Risk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Data443 Risk will offset losses from the drop in Data443 Risk's long position.

The idea behind Aerovate Therapeutics and Data443 Risk Mitigation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.